Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion description "[In this study, the effect of increased MTHFS expression on the efficacy of the glycinamide ribonucleotide formyltransferase (GARFT) inhibitor LY309887 was investigated in SH-SY5Y neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion evidence source_evidence_literature NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion SIO_000772 19022216 NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion wasDerivedFrom befree-20140225 NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion wasGeneratedBy ECO_0000203 NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.